Kapil Dhingra Insider Trading
Get free email notifications about insider trading for Kapil Dhingra.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kapil Dhingra. Kapil Dhingra is a Director in MICROMET, INC. ($MITI) and a Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and a Director in Black Diamond Therapeutics, Inc. ($BDTX) and a Director in Replimune Group, Inc. ($REPL).
Address: 39 BLISS AVENUE TENAFLY 07670 NJ
Companies in which Kapil Dhingra is an Insider
Black Diamond Therapeutics, Inc.
Trading Symbol: BDTXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Kapil Dhingra: Director
Holdings: 0 shares
Latest Transaction: Jun 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FIVE PRIME THERAPEUTICS, INC.
Trading Symbol: FPRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kapil Dhingra: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 19 2021
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MICROMET, INC.
Trading Symbol: MITIIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Kapil Dhingra: Director
Holdings: 0 shares
Latest Transaction: Jun 19 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Replimune Group, Inc.
Trading Symbol: REPLIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Kapil Dhingra: Director
Holdings: 40,000 shares
Latest Transaction: Apr 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Kapil Dhingra
Sentiment: All, BDTX, FPRX, MITI, REPL
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | BDTX | Black Diamond Ther ... | Dhingra Kapil | Director | Option Exercise | A | 12.55 | 15,000 | 188,250 | 15,000 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 4.14 | 20,000 | 82,800 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 6.09 | 15,000 | 91,350 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 17.27 | 10,000 | 172,700 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 29.80 | 10,000 | 298,000 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | D | 37.99 | 25,000 | 949,750 | 0 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Dhingra Kapil | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 |